{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:51:13Z","timestamp":1793659873502,"version":"4.5.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To evaluate the effect of publication of the ARRIVE (A Randomized Trial of Induction Versus Expectant Management) trial on perinatal outcomes in singleton, term, nulliparous patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>An interrupted time series analysis was performed using clinical data for nulliparous singleton births at 39 weeks of gestation or later at 13 hospitals in the Northwest region of the United States (January 2016\u2013December 2020). A modified Poisson regression was used to model time trends and changes after the ARRIVE trial (August 9, 2018). Outcomes of interest were elective induction, unplanned cesarean births, hypertensive disorders of pregnancy, a composite of perinatal adverse outcomes, and neonatal intensive care unit admissions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>The analysis included 28,256 births (15,208 pre-ARRIVE and 13,048 post-ARRIVE). The rate of elective labor induction was 3.6% during the pre-ARRIVE period (January 2016\u2013July 2018) and 10.8% post-ARRIVE (August 2018\u2013December 2020). In the interrupted time series analysis, elective induction increased by 42% (relative risk [RR] 1.42; 95% CI 1.18\u20131.71) immediately after the ARRIVE trial publication. Thereafter, the trend was unchanged compared with the pre-ARRIVE period. There was no statistically significant change in cesarean birth (RR 0.96; 95% CI 0.89\u20131.04) or hypertensive disorders of pregnancy (RR 0.91; 95% CI 0.79\u20131.06) immediately after the trial, and no change in trend. After the ARRIVE trial, there was no immediate change in adverse perinatal outcomes, but a statistically significant increase in trend of adverse perinatal events (1.03; 95% CI 1.01\u20131.05) when compared with a declining trend observed in the pre-ARRIVE period.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Publication of the ARRIVE trial was associated with an increase in elective induction, and no change in cesarean birth or hypertensive disorders of pregnancy in singleton nulliparous patients giving birth at 39 weeks or later. There was a flattening of the pre-ARRIVE decreasing trend in perinatal adverse events.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000005217","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T01:04:40Z","timestamp":1688691880000},"page":"242-250","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":31,"title":["Effects of the ARRIVE (A Randomized Trial of Induction Versus Expectant Management) Trial on Elective Induction and Obstetric Outcomes in Term Nulliparous Patients"],"prefix":"10.1097","volume":"142","author":[{"given":"Elizabeth","family":"Nethery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Sitcov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivienne L.","family":"Souter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"key":"R1-20250423","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1800566","article-title":"Labor induction versus expectant management in low-risk nulliparous women","volume":"379","author":"Grobman","year":"2018","journal-title":"N Engl J Med"},{"key":"R2-20250423","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.AOG.0000444441.04111.1d","article-title":"Safe prevention of the primary cesarean delivery. Obstetric Care Consensus No. 1. American College of Obstetricians and Gynecologists","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R3-20250423","doi-asserted-by":"crossref","first-page":"e005671-8","DOI":"10.1136\/bmjgh-2021-005671","article-title":"Trends and projections of caesarean section rates: global and regional estimates","volume":"6","author":"Betran","year":"2021","journal-title":"BMJ Glob Health"},{"key":"R4-20250423","article-title":"Births: provisional data for 2021","author":"Hamilton","year":"2022","journal-title":"National Center for Health Statistics"},{"key":"R5-20250423","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/jmwh.12996","article-title":"The ARRIVE trial \u2013 interpretation from an epidemiologic perspective","volume":"64","author":"Carmichael","year":"2019","journal-title":"J Midwifery Women\u2019s Health"},{"key":"R7-20250423","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2018.08.009","article-title":"SMFM statement on elective induction of labor in low-risk nulliparous women at term: the ARRIVE trial","volume":"221","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"R8-20250423","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/AOG.0000000000001294","article-title":"Cervical dilation on admission in term spontaneous labor and maternal and newborn outcomes","volume":"127","author":"Kauffman","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R9-20250423","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/birt.12606","article-title":"Impact of the COVID\u201019 pandemic on perinatal care and outcomes in the United States an interrupted time series analysis","volume":"49","author":"Riley","year":"2022","journal-title":"Birth"},{"key":"R14-20250423","first-page":"348","article-title":"Interrupted time series regression for the evaluation of public health interventions: a tutorial","volume":"46","author":"Bernal","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R15-20250423","doi-asserted-by":"crossref","first-page":"h2750","DOI":"10.1136\/bmj.h2750","article-title":"Regression based quasi-experimental approach when randomization is not an option: interrupted time series analysis","volume":"350","author":"Kontopantelis","year":"2015","journal-title":"BMJ Online"},{"key":"R16-20250423","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/24709360.2018.1477468","article-title":"Quasi-experimental design","volume":"4","author":"Maciejewski","year":"2020","journal-title":"Biostatistics Epidemiol"},{"key":"R17-20250423","doi-asserted-by":"crossref","first-page":"100474","DOI":"10.1016\/j.conctc.2019.100474","article-title":"Simulation-based power and sample size calculation for designing interrupted time series analyses of count outcomes in evaluation of health policy interventions","volume":"17","author":"Liu","year":"2020","journal-title":"Contemp Clin Trials Commun"},{"key":"R18-20250423","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified Poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"key":"R19-20250423","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/ije\/dyt092","article-title":"Time series regression studies in environmental epidemiology","volume":"42","author":"Bhaskaran","year":"2013","journal-title":"Int J Epidemiol"},{"key":"R20-20250423","doi-asserted-by":"crossref","first-page":"e003567-13","DOI":"10.1136\/bmjgh-2020-003567","article-title":"Use of interrupted time series methods in the evaluation of health system quality improvement interventions: a methodological systematic review","volume":"5","author":"Hategeka","year":"2020","journal-title":"BMJ Glob Health"},{"key":"R21-20250423","doi-asserted-by":"crossref","first-page":"100086","DOI":"10.1016\/j.ajogmf.2020.100086","article-title":"Patients\u2019 perspectives regarding induction of labor in the absence of maternal and fetal indications: are our patients ready for the ARRIVE trial?","volume":"2","author":"Gallagher","year":"2020","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R22-20250423","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1056\/NEJMoa1509117","article-title":"Randomized trial of labor induction in women 35 years of age or older","volume":"374","author":"Walker","year":"2016","journal-title":"N Engl J Med"},{"key":"R23-20250423","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/hr.2016.126","article-title":"Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis","volume":"40","author":"Umesawa","year":"2017","journal-title":"Hypertens Res"},{"key":"R24-20250423","first-page":"73","article-title":"Racial and ethnic inequities in cesarean birth and maternal Morbidity in a low-risk, nulliparous cohort","volume":"139","author":"Debbink","year":"2022","journal-title":"Obstet Gynecol"},{"key":"R25-20250423","doi-asserted-by":"crossref","first-page":"716.e1","DOI":"10.1016\/j.ajog.2022.02.003","article-title":"Changes in obstetric practices and pregnancy outcomes following the ARRIVE trial","volume":"226","author":"Gilroy","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"R26-20250423","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.socscimed.2017.12.005","article-title":"Understanding and misunderstanding randomized controlled trials","volume":"210","author":"Deaton","year":"2018","journal-title":"Social Sci Med"},{"key":"R27-20250423","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/S0140-6736(18)32205-0","article-title":"Implementation research: new imperatives and opportunities in global health","volume":"392","author":"Theobald","year":"2018","journal-title":"The Lancet"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T20:00:16Z","timestamp":1745438416000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005217","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,5]]},"assertion":[{"value":"2022-11-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}